Keywords: nexstar, hears, fda, news, daunoxome, pharmaceuticals, received
NeXstar hears FDA news on DaunoXome
Article | 16 October 1995
- NeXstar Pharmaceuticals has received approval from the UK regulatory authorities for DaunoXome (daunorubicin), a treatment for Kaposi's sarcoma. The company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
